Sanofi ADR Price To Earning vs. Price To Book

SNY Stock  USD 49.01  0.45  0.91%   
Considering Sanofi ADR's profitability and operating efficiency indicators, Sanofi ADR is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in June. Profitability indicators assess Sanofi ADR's ability to earn profits and add value for shareholders. At this time, Sanofi ADR's Price To Sales Ratio is fairly stable compared to the past year. EV To Sales is likely to rise to 4.20 in 2024, whereas Days Sales Outstanding is likely to drop 86.44 in 2024. At this time, Sanofi ADR's Net Income From Continuing Ops is fairly stable compared to the past year. Interest Income is likely to rise to about 573.3 M in 2024, whereas Accumulated Other Comprehensive Income is likely to drop slightly above 4.6 B in 2024.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.790.6152
Significantly Up
Very volatile
Net Profit Margin0.120.1254
Sufficiently Down
Pretty Stable
Operating Profit Margin0.220.2132
Sufficiently Up
Pretty Stable
Pretax Profit Margin0.210.1661
Significantly Up
Pretty Stable
Return On Assets0.07730.0427
Way Up
Very volatile
Return On Equity0.130.0729
Way Up
Very volatile
For Sanofi ADR profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sanofi ADR to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sanofi ADR utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sanofi ADR's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sanofi ADR over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.
Is Sanofi ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.43)
Earnings Share
1.92
Revenue Per Share
18.492
Quarterly Revenue Growth
0.023
Return On Assets
0.0454
The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Sanofi ADR Price To Book vs. Price To Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Sanofi ADR's current stock value. Our valuation model uses many indicators to compare Sanofi ADR value to that of its competitors to determine the firm's financial worth.
Sanofi ADR is currently regarded as top stock in price to earning category among related companies. It is currently regarded as top stock in price to book category among related companies fabricating about  0.19  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Sanofi ADR is roughly  5.39 . Price To Book Ratio is likely to drop to 1.44 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Sanofi ADR by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sanofi ADR's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sanofi ADR's earnings, one of the primary drivers of an investment's value.

Sanofi Price To Book vs. Price To Earning

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Sanofi ADR

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
7.78 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Sanofi ADR

P/B

 = 

MV Per Share

BV Per Share

 = 
1.44 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Sanofi Price To Book Comparison

Sanofi ADR is currently under evaluation in price to book category among related companies.

Sanofi ADR Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Sanofi ADR, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sanofi ADR will eventually generate negative long term returns. The profitability progress is the general direction of Sanofi ADR's change in net profit over the period of time. It can combine multiple indicators of Sanofi ADR, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income4.9 B4.6 B
Operating Income9.2 B8.7 B
Income Before Tax7.2 B5.6 B
Total Other Income Expense Net-2 B-2.1 B
Net Income5.4 B4.6 B
Income Tax Expense1.6 B1.2 B
Net Income Applicable To Common Shares9.6 B5.9 B
Net Income From Continuing Ops5.4 B6.3 B
Interest Income546 M573.3 M
Non Operating Income Net Other 0.00  0.00 
Net Interest Income-639 M-671 M
Change To Netincome-540 M-567 M
Net Income Per Share 4.31  2.69 
Income Quality 1.90  1.18 
Net Income Per E B T 0.75  0.67 

Sanofi Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Sanofi ADR. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sanofi ADR position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sanofi ADR's important profitability drivers and their relationship over time.

Use Sanofi ADR in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sanofi ADR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanofi ADR will appreciate offsetting losses from the drop in the long position's value.

Sanofi ADR Pair Trading

Sanofi ADR Pair Trading Analysis

The ability to find closely correlated positions to Sanofi ADR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sanofi ADR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sanofi ADR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sanofi ADR to buy it.
The correlation of Sanofi ADR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sanofi ADR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sanofi ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sanofi ADR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Sanofi ADR position

In addition to having Sanofi ADR in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cleaning Thematic Idea Now

Cleaning
Cleaning Theme
Compnanies producing and distributing cleaning products, supplies, and accessories. The Cleaning theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cleaning Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Sanofi ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanofi ADR's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanofi Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanofi Adr Stock:
Check out World Market Map.
For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Sanofi Stock analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
To fully project Sanofi ADR's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Sanofi ADR at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Sanofi ADR's income statement, its balance sheet, and the statement of cash flows.
Potential Sanofi ADR investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Sanofi ADR investors may work on each financial statement separately, they are all related. The changes in Sanofi ADR's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Sanofi ADR's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.